4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0001193125-26-266435
Director sold 600 shares at an average $241.70 ($145,017)
- Director acquired 1,429 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Mahony Susan · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-06-08 | Exercise or conversion : show line 1 in the form 10b5-1 | +1,429 | 1,429 | D | ||
| 2026-06-09 | Sale : show line 2 in the form 10b5-1 | −300 | $237.21 | $71,163 | 1,129 | D |
| 2026-06-10 | Sale : show line 3 in the form 10b5-1 | −300 | $246.18 | $73,854 | 829 | D |
| Open-market sales · 600 sh · avg $241.70 · $145,017 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-06-08 | Exercise or conversion : show line 4 in the form 10b5-1 Restricted Stock Units | −1,429 | 0 | D |
Loading xslF345X06/ownership.xml…